Inactive Instrument

Secunderabad Healthcare Limited

Equities

524540

INE930C01016

Healthcare Facilities & Services

Secunderabad Healthcare Ltd. cancelled the acquisition of majority stake in Astrel Genome Limited.

September 26, 2014 at 12:00 am

Secunderabad Healthcare Ltd. (BSE:524540) agreed to acquire majority stake in Astrel Genome Limited on September 26, 2013. The shareholders of Secunderabad Healthcare approved the deal on September 26, 2013.

Secunderabad Healthcare Ltd. (BSE:524540) cancelled the acquisition of majority stake in Astrel Genome Limited on September 26, 2014.

Latest news about Secunderabad Healthcare Limited

Secunderabad Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-29	CI
Secunderabad Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-29	CI
Secunderabad Healthcare Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2019	19-05-30	CI
Secunderabad Healthcare Limited Reports Unaudited Financial Results for the Third Quarter and Nine Months Ended December 31, 2018	19-02-14	CI
Secunderabad Healthcare Limited Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2018	18-08-22	CI
Secunderabad Healthcare Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2018	18-05-29	CI
Secunderabad Healthcare Ltd. Announces Unaudited Earnings Results for the Second Quarter and First Six Months Ended September 30, 2017	17-12-13	CI
Secunderabad Healthcare Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2017	17-09-14	CI
Secunderabad Healthcare Limited Announces Address Changes	17-06-13	CI
Secunderabad Healthcare Ltd. Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2017	17-05-30	CI
Secunderabad Healthcare Limited Announces Change in Directorate	17-05-18	CI
Secunderabad Healthcare Limited Reports Unaudited Standalone Financial Results for the Third Quarter and Nine Months Ended Dec. 31, 2016	17-02-13	CI
Secunderabad Healthcare Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and First Six Months Ended September 30, 2016	16-11-17	CI
Secunderabad Healthcare Announces Management Changes	16-06-28	CI
Secunderabad Healthcare Ltd. Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2016	16-05-27	CI
Secunderabad Healthcare Ltd Announces Address Change	16-05-20	CI
Secunderabad Healthcare Announces Board Changes	16-04-27	CI
Secunderabad Healthcare Ltd Announces Directorate Changes	16-03-07	CI
Secunderabad Healthcare Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015	16-02-18	CI
Secunderabad Healthcare Ltd. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2015	15-12-30	CI
Secunderabad Healthcare Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2015	15-11-28	CI
Secunderabad Healthcare Ltd. Announces Standalone Audited Earnings Results for the Fourth Quarter and Year Ended March 31, 2015	15-06-03	CI
Secunderabad Healthcare Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014	15-02-17	CI
Secunderabad Healthcare Ltd. Approves Jigar Premchand Motta as Independent Director	14-10-01	CI
Secunderabad Healthcare Ltd. cancelled the acquisition of majority stake in Astrel Genome Limited.	14-09-26	CI

Chart Secunderabad Healthcare Limited

Duration

Period

More charts

Company Profile

Secunderabad Healthcare Limited is an India-based healthcare company. The Company operates in the hospitals and medical services sector. The Company is developing mHealth, an application for mobile platform. The Company offers various services, including Healthcare Infrastructure Consulting, Healthcare Consulting, healthcare information technology and software services, and medical tourism. The Company's programs are focused on new products development related to lifestyle related diseases, such as diabetics, cardiovascular, anticoagulant, hypertension and chronic kidney disease. The Company is associated with various healthcare providers and works with them right from conceptualization, designing, commissioning and getting regulatory approvals in place, recruiting talent, resources allocation and implementing the project. The Company deals with emergency medicine, multi-specialty hospitals, nursing homes, private clinics, specialty clinics, rehabilitation and care providers.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
HCA HEALTHCARE, INC.	+18.69%	84.15B
CVS HEALTH CORPORATION	-25.20%	74.14B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.06%	26.92B
LABCORP HOLDINGS INC.	-10.46%	17.15B
FRESENIUS SE & CO. KGAA	-0.68%	16.83B
QUEST DIAGNOSTICS INCORPORATED	-0.73%	15.21B
NATERA, INC.	+72.88%	13.3B
TENET HEALTHCARE CORPORATION	+76.04%	12.99B
PURE HEALTH HOLDING	-25.79%	12.79B

Other Healthcare Facilities & Services